|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT02904252 |
|
Date of registration:
|
13/09/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Prevalence and Severity of HCV Infection in Thalassemia Major and Thalassemia Intermedia in Siriraj Hospital
|
|
Scientific title:
|
The Prevalence and Severity of HCV Infection in Thalassemia Major and Thalassemia Intermedia in Siriraj Hospital |
|
Date of first enrolment:
|
January 1, 2016 |
|
Target sample size:
|
158 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02904252 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Thailand
| | | | | | | |
|
Contacts
|
|
Name:
|
Tawesak Tanwandee, Assoc.Prof. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Division of Gastroenterology, Faculty of Medicine, Siriraj hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Previously diagnosed thalassemia major, for example homozygous beta thalassemia or
beta thalassemia/hemoglobin E disease or thalassemia intermedia such as hemoglobin H
disease or homozygous Hb CS
2. Age equal to or more than 18 years
3. Previous history of blood transfusion
Exclusion Criteria:
1. Patients who have hepatocellular carcinoma, ascites or pregnancy will be excluded from
the study due to the limitation of result interpretation.
2. Unwilling to participate
3. Patient who receiving or completed treatment of hepatitis C
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Hepatitis C
|
|
Fibrosis
|
|
Thalassemia
|
|
Intervention(s)
|
|
Other: Transient elastography
|
|
Primary Outcome(s)
|
|
Prevalence and genotypes of HCV infection in thalassemia major and thalassemia intermediate patients who have received blood transfusion in the Department of Medicine, Faculty of Medicine Siriraj Hospital
[Time Frame: 1 year]
|
|
Secondary Outcome(s)
|
|
Effect of HCV infection and the risk factors of advanced liver disease and liver cirrhosis in thalassemia major and thalassemia intermediate patients who have received blood transfusion
[Time Frame: 1 year]
|
|
Role of serum HA level and fibrotest in the prediction of cirrhosis in thalassemia major and thalassemia intermediate patients who have received blood transfusion in the Department of Medicine, Faculty of Medicine Siriraj Hospital.
[Time Frame: 1 year]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|